Two assays were employed: One measuring VWF cleavage at the surface of endothelial cells [31], the other simulating the cleavage of VWF-platelet complexes in circulation [32,33], which might be comparable to complexes that could be formed in a TTP scenario. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.